Browse the corpus

Calcium gluconate is a calcium salt crucial in managing hypocalcemia, cardiac arrest, and cardiotoxicity arising from hyperkalemia or hypermagnesemia. This activity discusses the diverse applications of calcium gluconate in clinical settings. By outlining its indications, mechanism of action, and contraindications, the activity equips healthcare team members with the essential knowledge to adeptly handle scenarios involving hypocalcemia, cardiac arrest, and cardiotoxicity due to hyperkalemia or hypermagnesemia. Adverse events, off-label uses, dosing, pharmacodynamics, monitoring, and relevant interactions will be discussed, ensuring a comprehensive understanding for healthcare professionals managing a spectrum of disorders associated with calcium imbalance. This activity is tailored for healthcare team members actively involved in addressing hypocalcemia, cardiac arrest, and cardiotoxicity due to hyperkalemia or hypermagnesemia, extending beyond routine clinical scenarios. The focus on critical aspects, ranging from the drug's mechanism of action to potential adverse events and nuanced dosing considerations, underscores its significance in diverse medical contexts. By immersing participants in a thorough exploration of calcium gluconate, this activity facilitates enhanced clinical decision-making, enabling healthcare professionals to optimize patient outcomes across a spectrum of calcium-related disorders. Objectives: Identify the indications and contraindications for calcium gluconate administration in various clinical scenarios. Determine the appropriate dosing and administration routes of calcium gluconate based on the specific condition being treated. Apply knowledge of calcium gluconate's pharmacology and mechanism of action to guide treatment decisions. Implement laboratory and diagnostic services to monitor and evaluate the effectiveness of calcium gluconate therapy. Access free multiple choice questions on this topic.

Calcium gluconate is a vesicant that can cause extravasation injury leading to tissue necrosis; see “Adverse Effects” above. Systemic toxicity due to calcium gluconate is identical to the systemic effects of hypercalcemia. Hypercalcemia typically manifests as nonspecific symptoms such as fatigue, muscle weakness, anorexia, and polydipsia. Hypercalcemia causes ECG changes, including short QT interval, prolonged PR interval, widened QRS, T wave abnormalities, and variable degrees of heart block.[20]

Calcium gluconate is indicated for various conditions, such as hypocalcemia, cardiac arrest, and cardiotoxicity due to hyperkalemia or hypermagnesemia, or is used off-label in managing calcium channel blocker and beta-blocker toxicity, magnesium toxicity, and hydrofluoric acid burns. Indications, route of administration, and dosage can be challenging and require an interprofessional team approach between various healthcare professionals, including physicians, advanced practice practitioners, nurses, and pharmacists. Calcium gluconate's various dosing units and conversion factors are potential sources of medication errors. Pharmacist input is essential to prevent dosing errors. Nursing has a role in addressing the extravasation of calcium gluconate in patients who present with symptoms after administration and monitoring EKGs in patients receiving treatment with calcium gluconate. It is imperative to use an interprofessional team-based approach when selecting, dosing, and administering this medication to ensure that patients receive the appropriate treatment and mitigate the adverse effects of the drug.